{"id":"https://openalex.org/W2948182500","doi":"https://doi.org/10.2337/db19-249-or","title":"249-OR: Empagliflozin Selected Cardiovascular and Safety Outcomes in Routine Care: First Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study","display_name":"249-OR: Empagliflozin Selected Cardiovascular and Safety Outcomes in Routine Care: First Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study","publication_year":2019,"publication_date":"2019-06-01","ids":{"openalex":"https://openalex.org/W2948182500","doi":"https://doi.org/10.2337/db19-249-or","mag":"2948182500"},"language":"en","primary_location":{"id":"doi:10.2337/db19-249-or","doi":"https://doi.org/10.2337/db19-249-or","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db19-249-or","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044474781","display_name":"Elisabetta Patorno","orcid":"https://orcid.org/0000-0002-8809-9898","observed_orcids":["https://orcid.org/0000-0002-8809-9898"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ELISABETTA PATORNO","raw_affiliation_strings":["Boston, MA, Ingelheim, Germany, Ridgefield, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA, Ingelheim, Germany, Ridgefield, CT","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102890723","display_name":"Ajinkya M Pawar","orcid":"https://orcid.org/0000-0002-8585-9505","observed_orcids":["https://orcid.org/0000-0002-8585-9505"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"AJINKYA PAWAR","raw_affiliation_strings":["Boston, MA, Ingelheim, Germany, Ridgefield, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA, Ingelheim, Germany, Ridgefield, CT","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074235726","display_name":"Jessica Myers Franklin","orcid":"https://orcid.org/0000-0002-8941-4116","observed_orcids":["https://orcid.org/0000-0002-8941-4116"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JESSICA FRANKLIN","raw_affiliation_strings":["Boston, MA, Ingelheim, Germany, Ridgefield, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA, Ingelheim, Germany, Ridgefield, CT","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044094148","display_name":"Mehdi Najafzadeh","orcid":"https://orcid.org/0000-0003-4503-1057","observed_orcids":["https://orcid.org/0000-0003-4503-1057"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MEHDI NAJAFZADEH","raw_affiliation_strings":["Boston, MA, Ingelheim, Germany, Ridgefield, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA, Ingelheim, Germany, Ridgefield, CT","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037108542","display_name":"Anouk D\u00e9ruaz\u2010Luyet","orcid":"https://orcid.org/0000-0001-7396-7392","observed_orcids":["https://orcid.org/0000-0001-7396-7392"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ANOUK DERUAZ-LUYET","raw_affiliation_strings":["Boston, MA, Ingelheim, Germany, Ridgefield, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA, Ingelheim, Germany, Ridgefield, CT","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036238582","display_name":"Kimberly Goodnow Brodovicz","orcid":"https://orcid.org/0000-0001-8275-1649","observed_orcids":["https://orcid.org/0000-0001-8275-1649"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KIMBERLY BRODOVICZ","raw_affiliation_strings":["Boston, MA, Ingelheim, Germany, Ridgefield, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA, Ingelheim, Germany, Ridgefield, CT","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028457317","display_name":"Steven Sambevski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"STEVEN SAMBEVSKI","raw_affiliation_strings":["Boston, MA, Ingelheim, Germany, Ridgefield, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA, Ingelheim, Germany, Ridgefield, CT","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030822229","display_name":"Lily Gui Bessette","orcid":"https://orcid.org/0000-0003-1088-8579","observed_orcids":["https://orcid.org/0000-0003-1088-8579"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"LILY G. BESSETTE","raw_affiliation_strings":["Boston, MA, Ingelheim, Germany, Ridgefield, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA, Ingelheim, Germany, Ridgefield, CT","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007262202","display_name":"Martin Kulldorff","orcid":"https://orcid.org/0000-0002-5284-2993","observed_orcids":["https://orcid.org/0000-0002-5284-2993"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MARTIN KULLDORFF","raw_affiliation_strings":["Boston, MA, Ingelheim, Germany, Ridgefield, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA, Ingelheim, Germany, Ridgefield, CT","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004416630","display_name":"Sebastian Schneewei\u00df","orcid":"https://orcid.org/0000-0003-2575-467X","observed_orcids":["https://orcid.org/0000-0003-2575-467X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SEBASTIAN SCHNEEWEISS","raw_affiliation_strings":["Boston, MA, Ingelheim, Germany, Ridgefield, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA, Ingelheim, Germany, Ridgefield, CT","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2035,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.57316052,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"68","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9380000233650208},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.9010000228881836},{"id":"https://openalex.org/keywords/heart-failure-hospitalization","display_name":"heart failure hospitalization","score":0.9610000252723694},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.8270000219345093},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.9750000238418579},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.9330000281333923},{"id":"https://openalex.org/keywords/diabetic-ketoacidosis","display_name":"diabetic ketoacidosis","score":0.8790000081062317},{"id":"https://openalex.org/keywords/lower-extremity-amputation","display_name":"lower limb amputation","score":0.8970000147819519},{"id":"https://openalex.org/keywords/bone-fractures","display_name":"bone fractures","score":0.8399999737739563},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.9980000257492065},{"id":"https://openalex.org/keywords/comparative-effectiveness","display_name":"comparative effectiveness","score":0.7789999842643738},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7120000123977661},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.5509999990463257}],"concepts":[{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.9786461591720581},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.86402827501297},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5606147050857544},{"id":"https://openalex.org/C2781283889","wikidata":"https://www.wikidata.org/wiki/Q1130148","display_name":"Diabetic ketoacidosis","level":3,"score":0.5139688849449158},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5111854672431946},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.41660749912261963},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3263234496116638},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.10948643088340759},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.08527609705924988}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db19-249-or","doi":"https://doi.org/10.2337/db19-249-or","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db19-249-or","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3010207927","https://openalex.org/W3035241156","https://openalex.org/W4393054462","https://openalex.org/W4281768514","https://openalex.org/W3176942856","https://openalex.org/W3210055886","https://openalex.org/W3176817582","https://openalex.org/W4313531576","https://openalex.org/W3035706815","https://openalex.org/W4318542298"],"abstract_inverted_index":{"EMPRISE":[0,171],"studies":[1],"the":[2,118,132],"effectiveness,":[3],"safety":[4,145,194],"and":[5,18,65,89,97,127,192,228],"healthcare":[6],"utilization":[7],"of":[8,36,79,117,131,144,184,190],"empagliflozin":[9],"(EMPA),":[10],"a":[11,50,56,112,128,160,181,193],"SGLT2":[12],"inhibitor,":[13],"using":[14],"data":[15,29],"from":[16,30,170],"Medicare":[17],"2":[19,45],"U.S.":[20,226],"commercial":[21],"claims":[22],"datasets":[23],"(2014-2019).":[24],"In":[25],"an":[26,66],"analysis":[27],"on":[28,209],"2014-2016,":[31],"we":[32],"identified":[33],"17,551":[34],"pairs":[35],"1:1":[37],"propensity":[38],"score-matched":[39],"patients":[40],"\u226518":[41],"years":[42],"with":[43,111,150,175,180,187,197],"type":[44],"diabetes":[46],"initiating":[47],"EMPA":[48,108,177],"or":[49,62,74],"DPP-4":[51],"inhibitor":[52],"(DPP-4i).":[53],"We":[54,93,158],"assessed":[55],"composite":[57],"CV":[58,68,119,134,185],"outcome":[59,69,120,135],"(MI,":[60],"stroke,":[61],"all-cause":[63],"mortality)":[64],"extended":[67,133],"(plus":[70],"heart":[71,138],"failure":[72,139],"hospitalization":[73,140],"coronary":[75],"revascularization).":[76],"Safety":[77],"outcomes":[78,146,186],"interest":[80],"were":[81,147],"lower-limb":[82],"amputations,":[83],"bone":[84],"fractures,":[85],"diabetic":[86],"ketoacidosis":[87],"(DKA),":[88],"acute":[90],"kidney":[91],"injury.":[92],"estimated":[94],"pooled":[95],"HR":[96],"95%":[98],"CI":[99],"adjusting":[100],"for":[101],">140":[102],"baseline":[103],"covariates.":[104],"Compared":[105],"to":[106,114],"DPP-4i,":[107,176],"was":[109,178],"associated":[110,179],"trend":[113],"lower":[115,129,182],"risk":[116,130,165,183],"[HR":[121],"(95%":[122],"CI)":[123],"=":[124],"0.82":[125],"(0.62-1.10)],":[126],"[0.73":[136],"(0.60-0.88)],":[137],"[0.56":[141],"(0.43-0.73)].":[142],"Risk":[143],"in":[148,163],"line":[149],"current":[151],"evidence":[152],"despite":[153],"small":[154],"numbers,":[155],"Table":[156],"1.":[157],"observed":[159],"numerical":[161],"increase":[162],"DKA":[164],"[1.74":[166],"(0.84-3.58)].":[167],"Early":[168],"findings":[169],"showed":[172],"that":[173],"compared":[174],"varying":[188],"levels":[189],"precision,":[191],"profile":[195],"consistent":[196],"currently":[198],"documented":[199],"information.":[200],"Disclosure":[201],"E.":[202],"Patorno:":[203],"Research":[204,223],"Support;":[205,224],"Self;":[206,213,225,234,239,251,259,273],"National":[207],"Institute":[208],"Aging.":[210],"Other":[211],"Relationship;":[212],"Boehringer":[214,240,252,260,278],"Ingelheim":[215,241,253,261,279],"International":[216,242,262],"GmbH.":[217,243,263],"A.":[218,236],"Pawar:":[219],"None.":[220,266,269],"J.":[221],"Franklin:":[222],"Food":[227],"Drug":[229],"Administration.":[230],"M.":[231,267],"Najafzadeh:":[232],"Consultant;":[233,272],"Epigenomics.":[235],"Deruaz-Luyet:":[237],"Employee;":[238,244,250,258],"Spouse/Partner;":[245],"Medtronic,":[246],"Sanofi.":[247],"K.":[248],"Brodovicz:":[249],"Pharmaceuticals,":[254],"Inc.":[255],"S.":[256,270],"Sambevski:":[257],"L.G.":[264],"Bessette:":[265],"Kulldorff:":[268],"Schneeweiss:":[271],"Aetion,":[274],"WHISCON,":[275],"LLC.":[276],"Funding":[277]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2019-06-14T00:00:00"}